Navigation Links
VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum

Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is absorbed into cancer cells and then attacking the DNA of those cancer cells.

The findings may help researchers design a new generation of anti-cancer drugs that selectively target cancer cells, reduce resistance and side effects and expand the range of tumors that can be treated by platinum.

In the Dec. 26 issue of the journal Inorganic Chemistry researchers reported on the design of a new trinuclear platinum compound and demonstrated that its cellular absorption is significantly greater than that of neutral cisplatin, as well as other multi-nuclear platinum compounds. The enhanced uptake into cancer cells takes advantage of weak molecular interactions on the cells' surface. These results underscore the importance of the new compound's "non-covalent" interactions, prior to the attack on DNA. Non-covalent interactions minimize potential side reactions and produce changes in the structure of proteins and DNA, which is different from currently used drugs. This research was selected as the cover article for the print version of the journal, Issue 26.

Researchers compared the cytotoxicity and cellular concentrations of three anti-cancer drugs including the phase II clinical drug, BBR 3464, cisplatin and the new trinuclear platinum compound. In a laboratory model, human ovarian cancer cells were exposed to each drug.

"In platinum antitumor chemistry our objective is to design and develop complexes acting by new mechanisms of action," said Nicholas Farrell, Ph.D., professor and chair in the Department of Chemistry at VCU, and lead author of the study. "Resistance to current drugs is due to poor cellular absorption and an increased ability of the cell to process or repair the damage caused by the chemotherapeutic agent."

"Our novel compou
'"/>

Source:Virginia Commonwealth University


Page: 1 2

Related biology news :

1. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
2. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
3. Massey researchers induce cell death in leukemia
4. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
5. Jump-starting T Cells In Skin Cancer
6. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
7. Fox Chase Cancer Center scientists identify immune-system mutation
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
10. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
11. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
Post Your Comments:
(Date:4/23/2014)... hungry diner ripping open a dinner roll, a fuel ... open a hydrogen molecule. Now researchers have captured a ... halves of its hydrogen feast. The view confirms previous ... catalyst work better for alternative energy uses. , This ... where the hydrogen halves end up in the structure ...
(Date:4/23/2014)... This news release is available in French ... , Montreal, 23 April 2014Today, the CEC released ... A Binational Collaborative Approach to Conservation, which identifies 29 ... States-Mexico border that includes 11 different protected areas in ... features unique, highly diverse arid and semi-arid habitats inhabited ...
(Date:4/23/2014)... A team of researchers in Korea ... the brains of nonhuman primates and assessed cell ... found that the hNSCs had differentiated into neurons ... , The study will be published in a ... is currently freely available on-line as an unedited ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Conservation priorities released for several protected areas along US-Mexico border 2Conservation priorities released for several protected areas along US-Mexico border 3Study finds long-term survival of human neural stem cells transplanted into primate brain 2
... at the University of Southampton today, Monday 23 August, ... in Europe, Photon10, the latest developments in ,green photonics, ... technologies undertaken by the United States, Optoelectronics Development Association ... will help reduce CO 2 -creating energy consumption will ...
... Jodie Holt , a professor of plant physiology at ... James Cameron,s film Avatar , will receive ... work as a distinguished scientist and educator" at a ceremony ... Diego Botanic Garden, 230 Quail Gardens Drive, Encinitas, Calif. ...
... NY, August 20, 2010The U.S. needs a comprehensive and ... it remains competitive in the global science and technology ... latest issue of OMICS: A Journal of Integrative ... Liebert, Inc. ( www.liebertpub.com ). The commentary is available ...
Cached Biology News:$240 billion of green photonics by 2021 2A plan to promote sustainable US scientific discovery and innovation in the 21st century is proposed in OMICS 2
(Date:1/15/2014)... The Pittcon Organizing Committee is pleased to announce that Innovative ... e-Journal and producer of Food Labs Conference , ... the co-location of Food Labs Conference to be held in ... fee to attend the two-day Food Lab Conference, March 4-5. ...
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer ... EmblemHealth , the New York ... the RedBrick Compass health assessment, combined with the RedBrick ... members. EmblemHealth is among the first health plans in ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... has been created that contains antibodies against coccidiosis, a ... writing in the open access journal BMC Biotechnology ... demonstrate their effectiveness in preventing this economically important illness. ... from Novoplant GmbH, Germany, to develop the seeds. He ...
... In a development that holds much promise for the ... use of solar energy to produce clean and renewable ... Energy,s Lawrence Berkeley National Laboratory (Berkeley Lab) have reported ... crystals of the semiconductor cadmium-selenide was increased 100,000 times. ...
... OAKS, Calif., Sept. 11 Amgen (Nasdaq: AMGN ) ... Monday, Sept. 14, 2009, at the Grand Hyatt hotel in New ... CEO Kevin Sharer will present at the conference. Live audio of ... accessed from Amgen,s Web site, www.amgen.com, under Investors. , ...
Cached Biology Technology:Gold solution for enhancing nanocrystal electrical conductance 2Gold solution for enhancing nanocrystal electrical conductance 3Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2
... SeMet White to off-white solid. Increases the ... HPLC. Soluble in H 2 O. ... use. RTECS EK7713840, CAS 3211-76-5, M.W. 196.1. ... 8515.Jornot, L., and Junod, A.F. 1995. ...
... pen has been designed to provide a thin film-like ... on a slide. This barrier creates the proper ... target area on the slide. PAP Pen contains ... acetone. It can be removed, if desired, by ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
...
Biology Products: